Director, Market Access Deal Analytics

<p>Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3D9IV8MzSvfOHVeWvrQ7Gpyyjf8oh2YbOImEae8XHfJeeKdWb5iMTG_i6gTGCiHtoMzE1iVTUEQk7IBNDvtrd8dbwJfMAYLK1NiNGH8FOf8LVClDRvtC2QLJLwxcJsj8r1Ife70mjBMpRU8D5q5PfAvDP5AbMwldlIcg5842srmwDavyrAg8tK_VpiNRaKqPlOSPLrCg1Yr2Gqdo5K6iwgZGVlm_WvFI8bMuPXMrqlgRQ%3D&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639171980%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=dWf%2FLVmCejjY3pM4XQok9nH8pF%2BfGwqWCZ8QwdWpTGQ%3D&reserved=0"><strong>www.axsome.com</strong></a> and follow us on <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DgkOAMVaudmIbjNO4LWBtZ25_8dkwL1L91EK22smznktgIMuoh5PltUd03J1ZN68KtUufEmLQRMgUjKqoa2Pb1ADSKI0zgay-rDcXd0R2wsbi9WIetngm8x8P1QX9OxhZQzuoPJMXr0UXnyGnIAbSvjwOT0oODGh2y6eODJbInNknBhQ4fXiSCd0LwP8PlS9T_Er2Q-RAoqsN_pVSx0k80cO9ivcvtqdJxZGSzZ37Ytmfmq-AThjSdP9ltWSUa2Fx&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639206174%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=ZofAOfLit%2FDztSC9U2W1xpx9HHF9z5bb4r1JDK9%2FVzo%3D&reserved=0"><strong>LinkedIn</strong></a> and <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DU4SjZsngAmgWDPNMBXhPfrWmLydithQ9boBRvsxUVxU58ik7Xm8tTepHofb6vjZMJpx1MvqLvCWWZ1wdmggQxeoNBfHWoTcIMhguJ4Da2DlcZj5Ye9BIcFvHHFTGURb_iGqk28bMXOs7pE8QmOShf7wSgJ0OVuMRyY31jlih0__WG9Q4dmEjE86yUY_8J0qo&data=05%7C02%7Cmsiegel%40axsome.com%7Cb0ad9a0787784e7305e308dda9c74deb%7Cb3096ec47bba4e2f9c92818dea8094e1%7C0%7C0%7C638853395639221688%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=Y85uAjK%2B8ysZNvbrHQAmApGPYT7mUKwtYyw%2FV0cvCcE%3D&reserved=0"><strong>X</strong></a>.</p> <p><strong><span data-contrast="none">About This Role </span></strong><span data-ccp-props="{"335551550":6,"335551620":6}"> </span></p> <p><span data-contrast="none">Axsome Therapeutics is seeking a Director, Market Access Deal Analytics to serve as a strategic leader in developing data-driven solutions that inform payer strategy, reimbursement optimization, pricing, and patient access. The ideal candidate will bring deep experience in payor and PBM deal analytics, strong understanding of payor incentives, Medicare and Medicaid reimbursement, understanding of specialty pharmacy, hub, patient services programs, and a pragmatic, action-oriented mindset that connects insights to execution. This position reports to the Seni